Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-22 Equity Swap | 2021-04-22 1:55 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Giles Lisa M. Director | 87,072 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:55 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Kagnoff Michael Director | 137,319 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:55 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Fox James Director | 263,102 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:54 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | FAULKNER DARYL Director | 133,871 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:54 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | OBOYLE KEVIN C Director | 131,678 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:54 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Stevenson Wade R. SVP, North America Sales | 50,000 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:53 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development | 101,324 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:53 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Winkler Sarah Hollis VP, Human Resources | 147,502 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:52 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Maderazo Alan Baer VP, Qual, Reg, & Clin Affairs | 262,180 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:51 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Jensen Tyler SVP, Engineering and Tech Dev | 212,249 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:51 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | O'Brien Scott Alexander SVP, Global Mktg & Int'l Sales | 170,879 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:51 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Chohan Abdul SVP Operations | 63,750 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:50 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Stier Eric SVP & General Counsel | 275,974 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:50 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Harkins Michael John SVP, Sales | 144,214 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:50 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Gleeson Michael SVP, Corp. Accounts | 451,452 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:49 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer | 232,993 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:49 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 622,689 | $24.05 | 0 (Direct) | View |